I've seen how misunderstood pain conditions like fibromyalgia, complex regional pain syndrome (CRPS), and even chronic aspects of multiple sclerosis or post-stroke syndromes can derail lives. That's why I'm excited to dive into the International Association for the Study of Pain (IASP)'s updated criteria for nociplastic pain — a game-changer for clinicians, patients, and caregivers alike.
This isn't just theory; it's a practical framework to identify when pain stems from altered nervous system processing, not ongoing tissue damage or nerve injury. We'll cover the latest research, real data from studies, diagnostic steps, and rehab-focused treatments to help you take control.
Nociplastic pain overlaps with many conditions like peripheral neuropathy, myasthenia gravis, frozen shoulder, or myofascial pain syndrome — where central changes amplify symptoms. Let's break it down with evidence and actionable insights.
What Is Nociplastic Pain?
Nociplastic pain is defined by the IASP as "pain that arises from altered nociception despite no clear evidence of actual or threatened tissue damage causing the activation of peripheral nociceptors or evidence for disease or lesion of the somatosensory system causing the pain" IASP Terminology, 2024 update . It's the third pain category alongside nociceptive (tissue damage) and neuropathic (nerve damage).
Data from a 2021 Lancet review shows nociplastic mechanisms underpin up to 20–30% of chronic pain cases worldwide, affecting millions Fitzcharles et al., Lancet 2021 . In fibromyalgia (a prototype), neuroimaging reveals altered pain matrix connectivity, with 30–50% higher glutamate levels in the insula and ACC Harris et al., J Neurosci 2008.
This table compares pain types — note how nociplastic lacks clear triggers but involves hypersensitivity.
The 2021 IASP Criteria Update: A Structured Framework
In November 2021, the IASP Terminology Task Force published clinical criteria for nociplastic pain in the musculoskeletal system in PAIN journal Kosek et al., PAIN 2021 . This builds on prior guidance, providing a grading system (possible/probable) for better diagnostic precision. A 2024 Nature Reviews Neurology update validates its use, with 85% inter-rater reliability in clinics Kaplan et al., Nat Rev Neurol 2024 .
The criteria emphasize a decision tree, aligning with central sensitization concepts from Jo Nijs' work Nijs et al., J Clin Med 2021 .
This flowchart from Kosek et al. (2021) shows the algorithm: Start with pain duration >3 months and regional spread.
Key Elements of the Criteria
Diagnosing nociplastic pain requires integrating multiple domains:
- Pain duration: >3 months (chronic threshold).
- Distribution: Regional, multifocal, or widespread (beyond one segment).
- Hypersensitivity: Evoked (e.g., allodynia to light touch) or spontaneous.
- Comorbidities: Sleep disturbance, fatigue, cognitive issues (assess via CSI >40).
A 2023 PMC study found 70% of fibromyalgia patients meet probable criteria, with CSI correlating to symptom severity (r=0.65) PMC10525501 .
Table 1: Nociplastic Pain vs. Other Types (Adapted from OpenAnesthesia, 2023)
| Feature | Nociplastic | Nociceptive | Neuropathic |
|---|---|---|---|
| Cause | Altered nociception (CNS changes) | Tissue damage/inflammation | Nerve lesion/dysfunction |
| Distribution | Widespread/regional | Localized to injury | Dermatomal |
| Hypersensitivity | Allodynia/hyperalgesia common | Hyperalgesia at site | Dysesthesia, allodynia |
| Examples | Fibromyalgia, IBS | Osteoarthritis, fractures | Diabetic neuropathy, post-herpetic neuralgia |
Mandatory Spreading of Pain
Pain must spread beyond a single segment (e.g., not just one joint) — this mandatory criterion reflects central amplification. Localized pain stays nociceptive/neuropathic until proven otherwise. Data from 1,200 patients shows spreading correlates with central sensitization in 82% of cases.
Excluding Other Pain Mechanisms
Rule out nociceptive (e.g., ongoing arthritis) and neuropathic (e.g., radiculopathy) as primary drivers. Use tools like DN4 questionnaire for neuropathy (sensitivity 83%). If mixed, nociplastic can coexist — e.g., in post-TKR with persistent pain Lavand'homme et al., Anesthesiology 2018.
This brain diagram illustrates neurochemical changes in nociplastic pain, including glutamate upregulation.
Possible vs. Probable Nociplastic Pain
- Possible: Meets basics (duration, spread, not fully explained by other mechanisms).
- Probable: Plus history of hypersensitivity + ≥1 comorbidity (e.g., fatigue, mood issues; CSI ≥40).
The Central Sensitization Inventory (CSI) is a validated 25-item tool Neblett et al., J Pain 2013. Score >40 indicates sensitization in 85% of cases.
Chronic pain relief new treatments: 9 Breakthrough Solutions 2025
Sample CSI questions: "I feel tired and unrefreshed when I wake from sleeping."
Practical Treatment: Rehab-Focused Strategies
Nociplastic pain responds best to central-targeted therapies. A 2024 review reports 40–60% improvement in function with multimodal care [Kaplan et al., 2024].
- Pain Neuroscience Education (PNE): Explains pain as brain output — reduces fear in 70% of patients Louw et al., Physiother Theory Pract 2016.
- Graded Exercise: Low-intensity aerobic + strength (e.g., 20 min walking 3x/week) modulates descending inhibition; meta-analysis shows 25% pain reduction Geneen et al., Cochrane 2017.
- Mind-Body: Mindfulness/CBT cuts symptoms by 30% Veehof et al., Pain 2016.
- Medications: SNRIs (duloxetine) for mood/pain overlap; low evidence for opioids.
For conditions like CRPS or fibromyalgia from your list, combine with modalities (TENS for gating).
This infographic outlines treatment approaches, emphasizing neuroplasticity.
Final Thoughts
Mastering these criteria empowers us to validate nociplastic pain early, shifting from "it's all in your head" to targeted care. For more, check the full PAIN article Kosek et al., 2021 or IASP resources . If you're dealing with this, start with CSI self-assessment here.
Share your thoughts: How has recognizing nociplastic pain changed your recovery? Let's discuss below.
Disclaimer: This is educational; consult your healthcare team.
0 Comments